Literature DB >> 17567458

Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?

Stephen H Caldwell1, Yoshihiro Ikura, Julia C Iezzoni, Zhenqi Liu.   

Abstract

Fatty liver is closely related to the development of the insulin resistance syndrome that largely results from abnormal insulin signaling in three major organs: (i) skeletal muscle in which insulin sensitivity depends on fat content and metabolic activity (exercise); (ii) adipose tissue, which serves as a reservoir of energy in the form of triglycerides; and (iii) the liver, which variably serves as a source or storage site of carbohydrates and lipids. In many respects, the fatty liver resembles a mixture of brown adipose tissue (microvesicular steatosis) and white adipose tissue (macrovesicular steatosis) including the stages of fatty droplet accumulation, and the expression of uncoupling proteins and perilipin-like substances. Furthermore, the development of an inflammatory infiltrate and the increased production of cytokines as occurs in adipose tissue, suggest that the liver in some individuals serves as an extension of adipose tissue. Moreover, current evidence indicates that these morphological changes represent altered gene expression similar to that of adipocytes. However, fatty liver does not appear to be a uniform feature of the metabolic syndrome and there is substantial variation in humans in the development of fatty liver independent of insulin resistance. In this regard, the variable development of fatty liver in Palmipedes (migratory fowl) and its close relationship to skeletal muscle utilization of fatty acids, lipoprotein metabolism and thermoregulation are instructive. The predilection to non-alcoholic fatty liver disease among some varieties of Palmipedes suggests that the development of fatty liver represents an adaptive process, closely integrated with skeletal muscle fat utilization and adipose tissue distribution, and facilitates survival in a very cold, resource-scarce environment. Variation in human populations with metabolic syndrome likewise suggests that the trait evolved in populations exposed in ancient times to different environmental challenges and, because the liver plays a central role in lipid metabolism, the presence or absence of fatty liver is likely to be integrated with insulin sensitivity in other target organs and with lipoprotein metabolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17567458     DOI: 10.1111/j.1440-1746.2006.04639.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  11 in total

1.  Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort.

Authors:  Veronica Wendy Setiawan; Daniel O Stram; Jacqueline Porcel; Shelly C Lu; Loïc Le Marchand; Mazen Noureddin
Journal:  Hepatology       Date:  2016-07-17       Impact factor: 17.425

Review 2.  Lipid droplet-associated proteins in alcoholic liver disease: a potential linkage with hepatocellular damage.

Authors:  Yoshihiro Ikura; Stephen H Caldwell
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 3.  Gender and racial differences in nonalcoholic fatty liver disease.

Authors:  Jen-Jung Pan; Michael B Fallon
Journal:  World J Hepatol       Date:  2014-05-27

Review 4.  Translational approaches: from fatty liver to non-alcoholic steatohepatitis.

Authors:  Natalia Rosso; Norberto C Chavez-Tapia; Claudio Tiribelli; Stefano Bellentani
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

5.  Liver enzymes, race, gender and diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  A L C Schneider; M Lazo; C E Ndumele; J S Pankow; J Coresh; J M Clark; E Selvin
Journal:  Diabet Med       Date:  2013-04-12       Impact factor: 4.359

6.  Inflammatory modulation of exercise salience: using hormesis to return to a healthy lifestyle.

Authors:  Alistair V Nunn; Geoffrey W Guy; James S Brodie; Jimmy D Bell
Journal:  Nutr Metab (Lond)       Date:  2010-12-09       Impact factor: 4.169

7.  Association between markers of fatty liver disease and impaired glucose regulation in men and women from the general population: the KORA-F4-study.

Authors:  Ina-Maria Rückert; Margit Heier; Wolfgang Rathmann; Sebastian E Baumeister; Angela Döring; Christa Meisinger
Journal:  PLoS One       Date:  2011-08-05       Impact factor: 3.240

Review 8.  Treatment of nonalcoholic steatohepatitis in adults: present and future.

Authors:  S Gitto; G Vitale; E Villa; P Andreone
Journal:  Gastroenterol Res Pract       Date:  2015-03-18       Impact factor: 2.260

9.  Racial differences in nonalcoholic fatty liver disease in the U.S. population.

Authors:  Andrea L C Schneider; Mariana Lazo; Elizabeth Selvin; Jeanne M Clark
Journal:  Obesity (Silver Spring)       Date:  2013-06-11       Impact factor: 5.002

Review 10.  Burden of hepatocellular carcinoma among hispanics in South Texas: a systematic review.

Authors:  John Ha; Aysha Chaudhri; Abhishek Avirineni; Jen-Jung Pan
Journal:  Biomark Res       Date:  2017-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.